Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTOR | P42345 | 20/20 | 0.54 |
| ▸ | PIK3CA | P42336 | 16/20 | 0.54 |
| ▸ | RICTOR | Q6R327 | 3/20 | 0.54 |
| ▸ | RPTOR | Q8N122 | 3/20 | 0.54 |
| ▸ | MAPKAP1 | Q9BPZ7 | 3/20 | 0.54 |
| ▸ | MLST8 | Q9BVC4 | 3/20 | 0.54 |
| ▸ | PIK3R1 | P27986 | 4/20 | 0.53 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30186894 | 0.82 | MTOR (0.57) | MTORPIK3CARICTORRPTORMAPKAP1 | |
| SCHEMBL4462376 | 0.81 | MTOR (0.48) | MTORPIK3CAPIK3R1PIK3CG | |
| SCHEMBL22838509 | 0.81 | MTOR (0.55) | MTORPIK3CARICTORRPTORMAPKAP1 | |
| SCHEMBL16238117 | 0.80 | PIK3CA (0.56) | MTORPIK3CAPIK3R1PIK3CG | |
| SCHEMBL2528288 | 0.80 | MTOR (0.45) | MTORPIK3CARICTORRPTORMAPKAP1 | |
| SCHEMBL29727937 | 0.79 | MTOR (0.56) | MTORPIK3CARICTORRPTORMAPKAP1 | |
| SCHEMBL21029901 | 0.79 | MTOR (0.56) | MTORPIK3CARICTORRPTORMAPKAP1 | |
| SCHEMBL28977909 | 0.79 | MTOR (0.56) | MTORPIK3CARICTORRPTORMAPKAP1 | |
| SCHEMBL1409520 | 0.79 | MTOR (0.56) | MTORPIK3CARICTORRPTORMAPKAP1 | |
| SCHEMBL2524177 | 0.76 | MAPK1 (0.58) | MTORPIK3CAPIK3R1PIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109414415-B | Treatment of skin lesions | 拓客股份有限公司 | 2023-05-02 | — | — | CN | disclosed |